Maternal Serum Screening Tests
"Maternal Serum Screening Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Analysis of the level of specific BIOMARKERS in a pregnant woman's sera to identify those at risk for PREGNANCY COMPLICATIONS or BIRTH DEFECTS.
| Descriptor ID |
D062145
|
| MeSH Number(s) |
E01.370.378.630.582
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Maternal Serum Screening Tests".
Below are MeSH descriptors whose meaning is more specific than "Maternal Serum Screening Tests".
This graph shows the total number of publications written about "Maternal Serum Screening Tests" by people in this website by year, and whether "Maternal Serum Screening Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 2 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Maternal Serum Screening Tests" by people in Profiles.
-
When ultrasound anomalies are present: An estimation of the frequency of chromosome abnormalities not detected by cell-free DNA aneuploidy screens. Prenat Diagn. 2018 03; 38(4):250-257.
-
The influence of noninvasive prenatal testing on gestational age at time of abortion for aneuploidy. Prenat Diagn. 2017 Jul; 37(7):635-639.
-
Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA). Prenat Diagn. 2016 May; 36(5):456-62.
-
What is the role of the 11- to 14-week ultrasound in women with negative cell-free DNA screening for aneuploidy? Prenat Diagn. 2016 Mar; 36(3):260-5.